| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 120.03B | 142.37B | 112.43B | 100.41B | 84.69B | 82.26B |
| Gross Profit | 22.75B | 26.49B | 20.64B | 20.17B | 18.85B | 19.74B |
| EBITDA | 11.60B | 14.88B | 9.85B | 9.79B | 8.62B | 9.50B |
| Net Income | 7.70B | 10.01B | 6.48B | 6.45B | 5.62B | 6.34B |
Balance Sheet | ||||||
| Total Assets | 107.00B | 113.87B | 105.48B | 95.28B | 88.94B | 82.66B |
| Cash, Cash Equivalents and Short-Term Investments | 28.38B | 25.74B | 24.47B | 34.60B | 32.25B | 35.59B |
| Total Debt | 20.94B | 14.75B | 18.23B | 12.75B | 12.10B | 12.64B |
| Total Liabilities | 33.00B | 32.74B | 32.55B | 27.25B | 25.92B | 23.74B |
| Stockholders Equity | 74.00B | 81.13B | 72.92B | 68.03B | 63.02B | 58.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.83B | -13.98B | 4.62B | -4.57B | 22.12B |
| Operating Cash Flow | 0.00 | 7.10B | -13.88B | 4.67B | -4.53B | 22.21B |
| Investing Cash Flow | 0.00 | -3.45B | 4.91B | -5.04B | 1.93B | 7.00M |
| Financing Cash Flow | 0.00 | -5.38B | 3.84B | -2.29B | -738.00M | -9.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥61.02B | 6.11 | ― | 3.64% | 26.63% | 54.32% | |
66 Neutral | ¥99.16B | 21.37 | ― | 2.19% | 3.42% | 7.82% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥109.03B | 6.95 | ― | 2.93% | 14.99% | 73.33% | |
61 Neutral | ¥115.21B | 7.31 | 15.81% | 2.93% | 12.51% | 12.42% | |
57 Neutral | ¥62.38B | 9.29 | ― | 2.89% | 4.32% | 11.25% | |
52 Neutral | ¥39.02B | 21.02 | ― | 0.45% | 23.11% | 8.31% |